Skip to Main Content

Paper Details

A hybrid breast cancer/mesenchymal stem cell population enhances chemoresistance and metastasis.
JCI Insight
2
2023
BCC, BCCs, C, C-, IL-6, MSC, MSCs, Patients, WNT5A, Wnt Family Member 5A, activation protein-, breast cancer, breast cancer cells, breast cancer/mesenchymal stem cell population, cancer, chemoresistant, hybrid, hybrid breast cancer/mesenchymal stem cell population, hybrid cancer cell population, hybrid cell, hybrid cell population, hybrid cells, mesenchymal stem/stromal cells, pancytokeratin, polyploid senescent cells, primary invasive carcinoma, primary tumors, triple-negative breast cancer, tumor
Author NameAffiliation
Sooryanarayana VaramballyUniversity of Alabama at Birmingham
Alexey I NesvizhskiiUniversity of Michigan Medical School ann arbor
Alexey I NesvizhskiiUniversity of Michigan ann arbor
Alexey I NesvizhskiiUniversity of Michigan Medical School ann arbor
Alexey I NesvizhskiiUniversity of Michigan ann arbor
Euisik YoonRogel Cancer Center and.
Euisik YoonUniversity of Michigan ann arbor
  • 1 - 7

Datasets

Release 1.2